| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0349baaeed78d816f85575e3ae8b90eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cb4ab729c5c94a203059e5d3f32dbeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9112c7aadfb11175de995dbbe3aa71c1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008 |
| filingDate |
2003-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd9116288f632597a3f7a34a10d64ad5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2345d91eb1c1ac313460046bb4959e12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aff2a310da932dbff9d1570614273e51 |
| publicationDate |
2010-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7704976-B2 |
| titleOfInvention |
Use of N-acetyl-D-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention |
| abstract |
The present invention discloses a use of N-acetyl-D-glucosamine in the manufacture of a medicament for treatment of urogenital tract infection. N-acetyl-D-glucosamine exhibits a function of suppressing the transplantation of exotic microorganisms and promoting the repair of topical skin tissue, and the formulation comprising it as a main active component is used for the prevention and treatment of urogenital tract infection and has advantages such as notable therapeutic effect, easy preparation, non-irritation, non-contamination, etc. |
| priorityDate |
2002-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |